COVID-19 test kit Zena Max

geneticbloodplasma

The Factor II Prothrombin “20210 Mutation” is a genetic condition that increases the likelihood of dangerous blood clots forming. All individuals make the Factor II prothrombin protein that helps blood clot. However, there are certain individuals who have a DNA mutation in the gene used to make prothrombin (also called prothrombin G20210A or the factor II mutation). These individuals have a thrombophilia (clotting disorder) called prothrombin G20210A which causes them to make too much of the prothrombin protein. Product Details: The assay is an in vitro PCR reaction assay for the Qualitative determination of Factor II Prothrombin 20210 Mutation DNA in the human sample such as Whole Blood and K2EDTA plasma based on Taqman detection method for Factor II Prothrombin (20210 mutation) with high sensitive one step qPCR kit. The Zena Max COVID-19 PCR kit is sensitive to 200 copies per “rxn volume 25ul” under our validation methods and devices. The specificity of the AMD Human Factor II Prothrombin “20210 Mutation” kit is up to 100% specific for Factor II Prothrombin “20210 Mutation” under our validation methods and devices.